News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioCapital
Incyte Corporation to Present at the UBS Warburg Global Life Sciences Conference
September 17, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 2008 UBS Global Life Sciences Conference on Tuesday, September 23, 2008 at 8:00 a.m. (Eastern Time).
Twitter
LinkedIn
Facebook
Email
Print
Events
Incyte
MORE ON THIS TOPIC
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
April 17, 2026
·
5 min read
·
Nick Paul Taylor
Rare diseases
Rare Disease Leaders Call for Regulatory Clarity as FDA Balances Urgency With Rigor
April 2, 2026
·
6 min read
·
Heather McKenzie
Immunology and inflammation
AAD 2026: Sanofi, Incyte, Roivant and Alumis Make Headway Into Skin Diseases
March 31, 2026
·
4 min read
·
Tristan Manalac
